CZ290816B6 - Způsob přípravy pastilek s obsahem flurbiprofenu - Google Patents

Způsob přípravy pastilek s obsahem flurbiprofenu Download PDF

Info

Publication number
CZ290816B6
CZ290816B6 CZ19994120A CZ412099A CZ290816B6 CZ 290816 B6 CZ290816 B6 CZ 290816B6 CZ 19994120 A CZ19994120 A CZ 19994120A CZ 412099 A CZ412099 A CZ 412099A CZ 290816 B6 CZ290816 B6 CZ 290816B6
Authority
CZ
Czechia
Prior art keywords
lozenge
flurbiprofen
mixture
forming composition
lozenges
Prior art date
Application number
CZ19994120A
Other languages
Czech (cs)
English (en)
Other versions
CZ412099A3 (cs
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of CZ412099A3 publication Critical patent/CZ412099A3/cs
Publication of CZ290816B6 publication Critical patent/CZ290816B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ19994120A 1997-05-22 1998-05-20 Způsob přípravy pastilek s obsahem flurbiprofenu CZ290816B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process

Publications (2)

Publication Number Publication Date
CZ412099A3 CZ412099A3 (cs) 2000-02-16
CZ290816B6 true CZ290816B6 (cs) 2002-10-16

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ19994120A CZ290816B6 (cs) 1997-05-22 1998-05-20 Způsob přípravy pastilek s obsahem flurbiprofenu

Country Status (31)

Country Link
US (1) US6194003B1 (https=)
EP (1) EP0983059B1 (https=)
JP (1) JP2001527567A (https=)
KR (1) KR20010012739A (https=)
CN (1) CN1154480C (https=)
AR (1) AR015812A1 (https=)
AT (1) ATE245021T1 (https=)
AU (1) AU725760B2 (https=)
BG (1) BG103881A (https=)
BR (1) BR9809651A (https=)
CA (1) CA2290830C (https=)
CZ (1) CZ290816B6 (https=)
DE (1) DE69816440T2 (https=)
DK (1) DK0983059T3 (https=)
ES (1) ES2202871T3 (https=)
GB (1) GB9710521D0 (https=)
HU (1) HU224954B1 (https=)
ID (1) ID22949A (https=)
IL (1) IL132999A0 (https=)
IN (1) IN187837B (https=)
MY (1) MY118410A (https=)
NO (1) NO995681L (https=)
NZ (1) NZ500664A (https=)
PL (1) PL190947B1 (https=)
PT (1) PT983059E (https=)
RU (1) RU2203046C2 (https=)
SK (1) SK283701B6 (https=)
TR (1) TR199902725T2 (https=)
UA (1) UA53714C2 (https=)
WO (1) WO1998052539A1 (https=)
ZA (1) ZA984260B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1235558T3 (da) 1999-12-09 2006-10-09 Reckitt Benckiser Healthcare Sammenpresset tabletsammensætning, der omfatter et NSAID
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
WO2009014960A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
AU2009284011B2 (en) * 2008-08-22 2013-12-12 Reckitt Benckiser Healthcare (Uk) Limited Sore throat compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
SMT202100228T1 (it) 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
RU2203046C2 (ru) 2003-04-27
BR9809651A (pt) 2000-07-11
JP2001527567A (ja) 2001-12-25
WO1998052539A1 (en) 1998-11-26
US6194003B1 (en) 2001-02-27
CN1255848A (zh) 2000-06-07
MY118410A (en) 2004-10-30
NO995681D0 (no) 1999-11-19
SK283701B6 (sk) 2003-12-02
HUP0002121A3 (en) 2001-04-28
EP0983059A1 (en) 2000-03-08
CA2290830C (en) 2006-07-11
AU725760B2 (en) 2000-10-19
GB9710521D0 (en) 1997-07-16
IN187837B (https=) 2002-06-29
PL190947B1 (pl) 2006-02-28
ES2202871T3 (es) 2004-04-01
AU7916598A (en) 1998-12-11
EP0983059B1 (en) 2003-07-16
DE69816440T2 (de) 2004-05-13
SK158899A3 (en) 2000-05-16
AR015812A1 (es) 2001-05-30
TR199902725T2 (xx) 2000-02-21
ZA984260B (en) 1999-02-20
CN1154480C (zh) 2004-06-23
PT983059E (pt) 2003-11-28
CA2290830A1 (en) 1998-11-26
NZ500664A (en) 2001-01-26
IL132999A0 (en) 2001-03-19
DK0983059T3 (da) 2003-11-03
UA53714C2 (uk) 2003-02-17
DE69816440D1 (de) 2003-08-21
KR20010012739A (ko) 2001-02-26
ATE245021T1 (de) 2003-08-15
HU224954B1 (en) 2006-04-28
PL336624A1 (en) 2000-07-03
CZ412099A3 (cs) 2000-02-16
NO995681L (no) 1999-11-19
HUP0002121A2 (hu) 2000-12-28
ID22949A (id) 1999-12-16
BG103881A (bg) 2000-05-31

Similar Documents

Publication Publication Date Title
CZ290816B6 (cs) Způsob přípravy pastilek s obsahem flurbiprofenu
RU2203655C2 (ru) Средство и способ облегчения симптомов больного горла
WO1998052545A1 (en) Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
JP2007517011A (ja) 経口デリバリーのための多粒子製剤
WO1998052540A1 (en) Pharmaceutical compositions
JP7751354B1 (ja) 結晶の製造方法
MXPA99010548A (en) Process for making flurbiprofen lozenges
MX2007009275A (es) Procedimiento de produccion de pastillas que contienen maine, sus composiciones y su uso medicinal.
JP7688467B1 (ja) 結晶の製造方法
JP7674575B1 (ja) 固形組成物
KR0132535B1 (ko) 외피와 내부코어로 구성된 연질정제의 제조방법
JP2026064979A (ja) 固形組成物、イブプロフェンの徐放性改善剤及び徐放性改善方法
JP2026064978A (ja) 固形組成物、イブプロフェンの溶出性改善剤及び溶出性改善方法

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20140520